Australia Hip Replacement Market Overview, 2031

Hip replacement market of Australia has shown steady performance, driven by rising incidences of osteoarthritis, aging demographics, and advancements in orthopedic care. Drivers of growth include increasing life expectancy, higher prevalence of joint-related disorders, and improved access to surgical facilities across both public and private healthcare systems. The purpose and benefits of hip replacement lie in restoring mobility, reducing pain, and improving quality of life for patients suffering from degenerative joint conditions. Historically, hip replacement surgeries were introduced in Australia in the mid-20th century, initially using cemented prostheses, with scope expanding in the 1990s to minimally invasive techniques and advanced biomaterials. The scope of products includes total hip replacement, partial hip replacement, and revision implants, with materials ranging from titanium alloys to ceramic-on-ceramic and polyethylene combinations. The scope of technology extends to robot-assisted surgery, 3D printing of implants, advanced imaging for pre-operative planning, and minimally invasive surgical techniques. Market components involve implant manufacturers, hospitals, orthopedic surgeons, distributors, and rehabilitation providers. Policies emphasize compliance with Therapeutic Goods Administration (TGA) regulations, hospital accreditation standards, and Medicare reimbursement frameworks. Challenges include high surgical costs, long waiting times in public hospitals, and risks of revision surgeries. Cultural trends highlight Australia’s strong focus on active aging, sports recovery, and patient-centric care, with customer behaviour showing preference for minimally invasive procedures, durable implants, and faster rehabilitation programs. Connection to the parent orthopedic devices market is strong, as hip replacement forms a critical sub-segment alongside knee and spinal implants, enabling comprehensive musculoskeletal care. The expansion of robot-assisted surgical platforms in metropolitan hospitals is accelerating adoption of advanced hip replacement procedures.

According to the research report, "Australia Hip Replacement Overview, 2031," published by Bonafide Research, the Australia Hip Replacement is anticipated to grow at more than 4.5% CAGR from 2026 to 2031.The competitive landscape of Australia’s hip replacement market blends global implant manufacturers with local distributors and healthcare providers. International firms such as Zimmer Biomet, Stryker, Johnson & Johnson (DePuy Synthes), and Smith & Nephew dominate, while local players like Exactech Australia, Orthopaedic Solutions, and Austofix provide regionally tailored offerings. Their products and services include total hip implants, revision systems, surgical instruments, and rehabilitation support. Local firms’ USPs lie in customized implant solutions, compliance with Australian standards, and strong surgeon engagement programs. Business models vary global firms emphasize large-scale hospital contracts and R&D-driven innovation, while local companies rely on direct distribution, surgeon partnerships, and niche specialization in revision and trauma implants. Price ranges differ significantly, basic hip replacement implants may cost AUD 5,000-8,000, while advanced ceramic or robotic-assisted systems can exceed AUD 15,000-25,000 depending on complexity. Market trends include adoption of minimally invasive surgery, expansion of robotic-assisted procedures, and integration of patient-specific 3D printed implants. Opportunities are strong in aging population care, sports injury recovery, and revision surgeries, where demand for advanced orthopedic solutions is rising. Latest news highlights Zimmer Biomet expanding robotic-assisted hip replacement programs in Australian hospitals, Stryker launching new ceramic implant lines, and Austofix collaborating with local universities on advanced biomaterials research. The market is also seeing growth in rehabilitation-focused partnerships and digital patient monitoring systems, reinforcing Australia’s role in advancing orthopedic innovation. Patients are increasingly seeking shorter hospital stays and outpatient surgery options, reshaping customer behaviour in orthopedic care. Several firms are piloting bioceramic and bioresorbable implant technologies, aiming to reduce revision surgery rates and improve outcomes.
The Australia hip replacement market is segmented into total hip replacement, partial hip replacement, hip resurfacing, revision hip replacement, hip replacement instruments, and hip replacement accessories, each addressing specific patient needs and clinical scenarios. Segmentation by product type highlights the diverse range of procedures, tools, and accessories shaping Australia’s hip replacement market across different patient demographics and clinical requirements. Total hip replacement remains the most widely performed procedure, involving replacement of both the femoral head and acetabulum. In Australia, this segment dominates due to its effectiveness in treating advanced osteoarthritis, fractures, and degenerative joint diseases, offering long‑term pain relief and improved mobility. Partial hip replacement, which replaces only the femoral head, is typically used for elderly patients with hip fractures or localized damage. In Australia, demand is steady in geriatric care, as it provides quicker recovery and reduced surgical complexity compared to total replacement. Hip resurfacing is a less invasive alternative, preserving more of the patient’s natural bone. In Australia, it is particularly suited for younger, active patients seeking durability and flexibility, though adoption is moderated by concerns over metal‑on‑metal implants. Revision hip replacement addresses cases where previous implants fail due to wear, loosening, or infection. In Australia, this segment is growing as the aging population and longer implant lifespans increase the need for corrective surgeries. Hip replacement instruments, including surgical tools, navigation systems, and robotics, play a critical role in ensuring precision and reducing complications. In Australia, hospitals and orthopedic centers are investing in advanced instruments to improve surgical outcomes. Hip replacement accessories, such as liners, spacers, and fixation devices, support implant stability and customization. In Australia, these products enhance patient‑specific solutions and extend implant longevity.

The Australia hip replacement market is segmented into hospitals, ambulatory surgical centers, orthopedic clinics, specialty care centers, and academic medical centers, each reflecting unique roles in delivering orthopedic care. Segmentation by end‑user highlights how hospitals anchor mainstream demand, ASCs drive efficiency, clinics sustain personalized care, specialty centers advance innovation, and academic institutions foster research and training within Australia’s hip replacement market. Hospitals remain the primary end‑users, performing the majority of hip replacement procedures due to their comprehensive infrastructure, advanced surgical equipment, and ability to manage complex cases. In Australia, hospitals cater to both emergency trauma patients and elective surgeries, with public hospitals ensuring accessibility and private hospitals offering specialized services and shorter waiting times. Ambulatory surgical centers (ASCs) are gaining traction as cost‑effective alternatives, focusing on minimally invasive hip replacement procedures that allow quicker recovery and same‑day discharge. In Australia, ASCs appeal to patients seeking convenience, affordability, and reduced hospital stays, particularly for partial replacements and resurfacing. Orthopedic clinics provide specialized care, often serving as referral points for diagnosis, pre‑operative planning, and post‑operative rehabilitation. In Australia, these clinics emphasize personalized treatment, outpatient consultations, and continuity of care, making them vital for patient engagement and long‑term outcomes. Specialty care centers, dedicated to musculoskeletal and joint health, offer advanced expertise and tailored solutions for complex hip disorders. In Australia, they are increasingly equipped with robotic surgery systems and advanced imaging technologies, supporting precision and innovation in hip replacement procedures. Academic medical centers play a dual role, combining patient care with research and training. In Australia, they contribute to clinical trials, development of new implant technologies, and education of orthopedic surgeons, ensuring continuous advancement in the field.

The Australia hip replacement market is segmented into primary hip replacement, revision hip replacement, minimally invasive hip replacement, robot‑assisted hip replacement, and computer‑assisted hip replacement, each reflecting different clinical needs and technological advancements. Segmentation by procedure type highlights how primary replacements anchor demand, revisions address long‑term implant management, minimally invasive techniques enhance recovery, and advanced robotic and computer‑assisted methods drive innovation in Australia’s hip replacement market. Primary hip replacement remains the most common procedure, performed to treat severe osteoarthritis, fractures, and degenerative joint conditions. In Australia, this segment dominates due to the aging population and rising prevalence of musculoskeletal disorders, offering patients long‑term pain relief and improved mobility. Revision hip replacement is required when existing implants fail due to wear, loosening, or infection. In Australia, demand for revision procedures is increasing as implant lifespans extend and more patients undergo corrective surgeries, requiring advanced techniques and durable materials. Minimally invasive hip replacement is gaining traction, emphasizing smaller incisions, reduced blood loss, and faster recovery times. In Australia, this approach appeals to patients seeking shorter hospital stays and quicker rehabilitation, particularly in private healthcare settings. Robot‑assisted hip replacement represents a growing innovation, enhancing surgical precision, implant alignment, and consistency of outcomes. In Australia, hospitals and specialty centers are adopting robotic systems to improve accuracy and reduce complications, making them attractive for complex cases and younger patients requiring long‑term implant performance. Computer‑assisted hip replacement, utilizing navigation systems and digital imaging, supports surgeons in achieving optimal positioning and alignment. In Australia, this technology is increasingly integrated into orthopedic practices, ensuring improved outcomes and reducing revision risks.

Considered in this report
•Historic Year: 2020
•Base Year: 2025
•Estimated Year: 2026
•Forecast Year: 2031

Aspects covered in this report
• Australia Hip Replacement Market with its value and forecast along with its segments
• Various drivers and challenges
• Ongoing trends and developments
• Top profiled companies
• Strategic recommendation



By Product Type
• Total Hip Replacement
• Partial Hip Replacement
• Hip Resurfacing
• Revision Hip Replacement
• Hip Replacement Instruments
• Hip Replacement Accessories

By End-User
• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Specialty Care Centers
• Academic Medical Centers

By Procedure Type
• Primary Hip Replacement
• Revision Hip Replacement
• Minimally Invasive Hip Replacement
• Robot-Assisted Hip Replacement
• Computer-Assisted Hip Replacement